A Study of Different Doses of Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)
Clinical trial NCT02801578 · COMPLETED
Trial details
- NCT number
- NCT02801578
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-06
- Primary completion
- 2019-01-28
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.